Showing posts with label Cancer. Show all posts
Showing posts with label Cancer. Show all posts

Thursday, March 3, 2011

Evidence-Based Nutrition Guidelines Needed For Cancer Survivors


Cancer survivors die of non-cancer-related causes at much higher rates than the general public. In 2008, the U.S. economic burden of cancer totaled over $228 billion but only 41% of these costs involved direct cancer care. The majority of expenses were attributed to increased morbidity, lost productivity, and premature mortality. A commentary published in the March 2011 issue of the Journal of the American Dietetic Association examines the current evidence supporting nutrition recommendations for preventing cancer recurrence and managing chronic conditions prevalent in cancer survivors, as well as improving quality of life and decreasing health care costs. The commentary also describes knowledge gaps and suggests future nutrition research directions.

"As the number of cancer survivors continues to increase, opportunities to conduct longer-term research are expanding," commented lead author Kim Robien, PhD, RD, Assistant Professor, Division of Epidemiology and Community Health; and Member, Cancer Outcomes and Survivorship Program, Masonic Cancer Center, University of Minnesota, Minneapolis. "With over 12 million American cancer survivors (about 4% of the population), it is time to concentrate on guidelines to help patients avoid the other complications that lead to death. Data support the hypothesis that nutrition interventions are not only likely to help with cancer outcomes, but can also be important in preventing and managing some of the chronic health conditions that can occur after cancer treatment, such as cardiovascular complications, weight gain, diabetes and other endocrine disorders, functional impairment, osteopenia and osteoporosis."


The authors discuss current recommendations for cancer survivors, which emphasize achieving and maintaining a healthy weight; encouraging regular physical activity (for adults at least 30 minutes of moderate to vigorous physical activity every day); eating a diet rich in vegetables, fruits, and whole grains; and limiting red and processed meats and alcohol consumption. Further, the current recommendations are that cancer survivors try and obtain their nutrients from foods, rather than supplements since there have been several studies that have linked supplement intake with higher cancer-specific and all-cause mortality among cancer survivors.


Important knowledge gaps that call for further research are identified. Because most cancer patients have one or more comorbid conditions, management of these comorbidities by nutritional interventions may improve quality of life for these individuals. Another area of investigation is whether specific cancers require specific nutritional guidelines.


Finally, the authors recognize that any nutritional intervention must work with the individual patient. Despite efforts by the American Cancer Society and the World Cancer Research Fund/American Institute for Cancer Research to encourage cancer survivors to follow diet and lifestyle recommendations for cancer prevention, evidence suggests that few cancer survivors are doing so. Further research is needed to determine the optimal method and timing of interventions to promote healthy lifestyle behaviors among cancer survivors.

Saturday, February 12, 2011

High School Students Graduating To Be Tomorrow's Cancer And Cardiovascular Patients, Australia



Results of a national diet and physical activity survey of high school students, released today (9 Feb), will ring alarm bells among educators, health professionals and parents.

The research, by Cancer Council and the Heart Foundation, reveals excessive prevalence of overweight and obesity among students (highest in low SES areas), inadequate rates of physical activity, insufficient fruit and vegetable intake and a high proportion of students making food choices based on advertising.


The participation of 12,000 students in years eight to 11 across 237 schools provides the first truly national sample for a physical activity survey of young Australians since 1985.


Key findings:


- One in four students are overweight or obese, with a significantly higher rate in low SES areas.


- Eighty-five per cent of students don't engage in sufficient activity to provide a health benefit.


- Low fruit and vegetable intake, with 76% not meeting the daily recommended intake of four vegetable servings daily and 59% not meeting the daily recommended intake of three servings of fruit daily.


- One third drink four or more cups of soft drink, cordial or sports drink a week


- More than half (51%) tried a new food or drink product in the past month they had seen advertised.


Cancer Council Australia CEO, Professor Ian Olver, said the findings confirmed what health experts had been saying for years, that poor nutrition and inadequate exercise were contributing to an unprecedented number of overweight and obese adolescents and a "chronic disease time bomb".


"If ever there was a wake-up call for Australians, this is it," Professor Olver said. "As obese kids move into adulthood the heightened risk of chronic diseases like cancer means previous gains in life expectancy may be reversed. We may see today's teenagers die at a younger age than their parents' generation for the first time in history"


National Heart Foundation of Australia CEO, Dr Lyn Roberts, said that all policy makers should be deeply disturbed by the findings.


"This piece of research confirms what we've feared for some time - that the high school students of today will grow up to be the heart attack victims of tomorrow," Dr Roberts said.


Chair of Cancer Council Australia's Nutrition and Physical Activity Committee, Kathy Chapman, said the report provided compelling evidence for the Australian Government to implement a comprehensive obesity strategy, as recommended by the National Preventative Health Taskforce.


"Overweight and obesity significantly increase cancer risk and unless we address the problem, common cancers such as bowel and breast cancer will surge," Ms Chapman said.


Source:
Cancer Council Australia

Bookmark and Share

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.


All opinions are moderated before being added.


Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.


If you write about specific medications or operations, please do not name health care professionals by name.


Contact Our News Editors


For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:






View the original article here

Wednesday, January 12, 2011

Nuclear Receptors Reveal Possible Interventions For Cancer, Obesity


Research with significant implications in the treatment and intervention of cancer and obesity has been published recently in two prestigious journals by University of Houston (UH) biochemist Dr. Jan-Ake Gustafsson.

In an invited review in the Journal of Biological Chemistry, the most-cited biomedical research journal in the world, Gustafsson and his team summarize the most recent results pertaining to the function of a nuclear receptor called estrogen receptor beta, or ERbeta, the biological and medical importance of which Gustafsson and his associates discovered in 1995. In the article, titled "Estrogen Signaling via Estrogen Receptor Beta," the group found that this regulatory molecule prevents what is called epithelial-to-mesenchymal transition, or EMT, in the prostate gland. EMT is believed to have an essential role in prostate tumor development. ERbeta also has a growth-suppressive effect in colon cancer cells.


All of this, added to new insights gained by the researchers regarding ERbeta's interaction with certain genetic materials, suggests that this molecule is potentially an interesting pharmaceutical target in many diseases, including cancer.


A second article by Gustafsson and his group appeared in a recent issue of the journal Proceedings of the National Academy of Sciences, one of the world's most-cited multidisciplinary scientific serials. Titled "Both liver-X receptor (LXR) isoforms control energy expenditure by regulating Brown Adipose Tissue activity," the research shows that two specific nuclear receptors - LXRalfa and LXRbeta - act in such a way as to indicate they have a crucial role in regulating energy homeostasis, which is important to maintain the stability of normal biological states during adjustments to environmental changes. Gustafsson suggests, then, that these molecules should be considered as targets in pharmaceutical intervention against obesity.


Both studies were performed in collaboration with Gustafsson's colleagues from the Karolinska Institute in Sweden, where he continues his duties as a member of the Center for Biotechnology at Huddinge University Hospital at the Karolinska Institute. He also holds an appointment as an adjunct professor at Baylor College of Medicine in Houston. Since 2009, his primary duties are as the Robert A. Welch Professor in UH's biology and biochemistry department and director of the Center for Nuclear Receptors and Cell Signaling, a collaborative effort between UH and The Methodist Hospital Research Institute.


In addition to holding both a Ph.D. and M.D., Gustafsson was recently invited by the University of Turku in Finland to accept an honorary doctorate from its faculty of medicine during the institution's graduation ceremony to be held in May.


Source:
Lisa Merkl
University of Houston

Bookmark and Share

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.


All opinions are moderated before being added.


Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.


If you write about specific medications or operations, please do not name health care professionals by name.


Contact Our News Editors


For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:






View the original article here